BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36849627)

  • 1. The significance of galactose-deficient immunoglobulin A1 staining in kidney diseases with IgA deposition.
    Tang X; Zheng J; Jiang X; Wan F; Hou X; Liu S; Zhang M; Song Y; Ye T; Yu J
    Int Urol Nephrol; 2023 Aug; 55(8):2119-2129. PubMed ID: 36849627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L; Peng L; Yang D; Chen S; Lan Z; Zhu X; Yuan S; Chen G; Liu Y; Liu H
    Clin Immunol; 2020 Aug; 217():108483. PubMed ID: 32479989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis.
    Suzuki H; Yasutake J; Makita Y; Tanbo Y; Yamasaki K; Sofue T; Kano T; Suzuki Y
    Kidney Int; 2018 Mar; 93(3):700-705. PubMed ID: 29329643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients.
    Cheng W; Wang G; Guo W; Sun L; Xu X; Dong H; Ye S; Geng Y; Cheng H
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K; Li Q; Zhang Y; Shang W; Wei L; Li H; Gao S; Yan T; Jia J; Liu Y; Lin S
    Kidney Blood Press Res; 2019; 44(5):1196-1206. PubMed ID: 31574506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy.
    Lee M; Suzuki H; Kato R; Fukao Y; Nakayama M; Kano T; Makita Y; Suzuki Y
    CEN Case Rep; 2021 Feb; 10(1):17-22. PubMed ID: 32676896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy.
    Yasutake J; Suzuki Y; Suzuki H; Hiura N; Yanagawa H; Makita Y; Kaneko E; Tomino Y
    Nephrol Dial Transplant; 2015 Aug; 30(8):1315-21. PubMed ID: 26109484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular galactose-deficient IgA1 expression analysis in pediatric patients with glomerular diseases.
    Ishiko S; Horinouchi T; Fujimaru R; Shima Y; Kaito H; Tanaka R; Ishimori S; Kondo A; Nagai S; Aoto Y; Sakakibara N; Nagano C; Yamamura T; Yoshimura M; Nakanishi K; Fujimura J; Kamiyoshi N; Nagase H; Yoshikawa N; Iijima K; Nozu K
    Sci Rep; 2020 Aug; 10(1):14026. PubMed ID: 32820208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KM55 Monoclonal Antibody Staining in IgA-Dominant Infection-Related Glomerulonephritis.
    Zhang M; Zhou W; Liu S; Zhang L; Ni Z; Hao C
    Nephron; 2021; 145(3):225-237. PubMed ID: 33596564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: A multicenter prospective observational study.
    Sofue T; Oguchi H; Yazawa M; Tsujita M; Futamura K; Nishihira M; Toyoda M; Kano T; Suzuki H
    PLoS One; 2023; 18(2):e0281945. PubMed ID: 36795799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid progression to end-stage renal disease in a child with IgA-dominant infection-related glomerulonephritis associated with parvovirus B19.
    Shirai Y; Miura K; Yabuuchi T; Nagasawa T; Ishizuka K; Takahashi K; Taneda S; Honda K; Yamaguchi Y; Suzuki H; Suzuki Y; Hattori M
    CEN Case Rep; 2020 Nov; 9(4):423-430. PubMed ID: 32621069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of clinical and pathological features of secondary IgA nephropathy of ankylosing spondylitis and primary IgA nephropathy.
    Zhang G; Tian Z; Xue Q
    Clin Nephrol; 2022 May; 97(5):273-280. PubMed ID: 35072620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy.
    Sugiyama M; Wada Y; Kanazawa N; Tachibana S; Suzuki T; Matsumoto K; Iyoda M; Honda H; Shibata T
    PLoS One; 2020; 15(4):e0232194. PubMed ID: 32324811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
    Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 36166247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KM55 in the Evaluation of IgA-Containing Glomerular Diseases.
    Raj R; Sharma A; Barwad A; Bagchi S; Agarwal SK; Bagga A; Dinda AK; Singh G
    Glomerular Dis; 2022 Apr; 2(2):59-74. PubMed ID: 36751531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy.
    Misaki T; Naka S; Suzuki H; Lee M; Aoki R; Nagasawa Y; Matsuoka D; Ito S; Nomura R; Matsumoto-Nakano M; Suzuki Y; Nakano K
    PLoS One; 2023; 18(3):e0282367. PubMed ID: 36862654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactose-Deficient IgA1-Specific Antibody Recognizes GalNAc-Modified Unique Epitope on Hinge Region of IgA1.
    Yamasaki K; Suzuki H; Yasutake J; Yamazaki Y; Suzuki Y
    Monoclon Antib Immunodiagn Immunother; 2018 Dec; 37(6):252-256. PubMed ID: 30570353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of galactosyl-deficient IgA1 by the monoclonal antibody KM55 contributes to predicting patients with IgA nephropathy with high risk of long-term progression.
    Martín-Penagos L; Fernández-Fresnedo G; Benito-Hernández A; Mazón J; de Cos M; Oviedo MV; San Segundo D; López-Hoyos M; Gómez-Román J; Ruiz JC; Rodrigo E
    Nefrologia (Engl Ed); 2021; 41(3):311-320. PubMed ID: 33741175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of glomerular Gd-IgA1 staining for indistinguishable cases of IgA nephropathy or Alport syndrome.
    Ishiko S; Tanaka A; Takeda A; Hara M; Hamano N; Koizumi M; Ueno T; Hayashi H; Kondo A; Nagai S; Aoto Y; Sakakibara N; Nagano C; Horinouchi T; Yamamura T; Ninchoji T; Shima Y; Nakanishi K; Yoshikawa N; Iijima K; Nozu K
    Clin Exp Nephrol; 2021 Jul; 25(7):779-787. PubMed ID: 33743099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
    Vignon M; Cohen C; Faguer S; Noel LH; Guilbeau C; Rabant M; Higgins S; Hummel A; Hertig A; Francois H; Lequintrec M; Vilaine E; Knebelmann B; Pourrat J; Chauveau D; Goujon JM; Javaugue V; Touchard G; El Karoui K; Bridoux F
    Kidney Int; 2017 Mar; 91(3):720-728. PubMed ID: 28069266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.